Abstract
Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1.
Lingua originale | English |
---|---|
Numero di pagine | 3 |
Rivista | Clinical Gastroenterology and Hepatology |
Stato di pubblicazione | Published - 2020 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.2700.2721???
- ???subjectarea.asjc.2700.2715???